Return

NL4TB: Novel Narrow Spectrum Antibiotic against Mycobacteria

Description

Achievements

•200 synthetized analogues à Anti-tuberculosis MIC - 10 nM
•Active on non-replicating drug tolerant tuberculosis
•Mycobacterium specific inhibitor of electron transport (image)
•No cytotoxicity


Pharmacokinetic/ADME properties:

  • 400 < MW < 550 g.mol-1 ;   3.5 < LogD < 5, High solubility
  • Chemically and metabolically stable
  • In vivo t1/2  > 6 h; Cmax > 10 µM, accumulation in lungs
  • In vivo POC established in M. marinum infected zebrafish

Sheet

Download the offer

Fields

Medical and health technologies